Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Endoscopic Ultrasound-Guided Radiofrequency Ablation for Pancreatic Cystic Neoplasms and Neuroendocrine Tumors

NCT07536087 is registered in ClinicalTrials.gov with Institute for Clinical and Experimental Medicine as lead sponsor.

NCT NCT07536087
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07536087 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Endoscopic Ultrasound-Guided Radiofrequency Ablation for Pancreatic Cystic Neoplasms and Neuroendocrine Tumors
Lead sponsor
Institute for Clinical and Experimental Medicine
Phase
Not applicable
Overall status
Recruiting
Start date
April 11, 2026
Completion date
December 31, 2029
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endoscopic ultrasound-guided radiofrequency ablation, pancreatic cystic neoplasms, pancreatic neuroendocrine tumors (pnet)